Rainbow Children's Medicare Ltd
Financial Results approved in the Board Meeting dated March 23, 2026.
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 27 May 2026, 04:03 PM IST · BSE ID: dbcc983d-b546-4640-a340-58ee28fc02e5
View Original BSE Filing (PDF)
💡
In Simple Terms
The company approved its full-year financial results, proposed a ₹3.5 dividend, and re-appointed key directors.
🤖 AI Summary
- Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026.
- Recommended a final dividend of ₹3.5 per Equity Share (@ 35%) on ₹10 face value for FY26.
- The 28th Annual General Meeting (AGM) is scheduled for Wednesday, July 29, 2026.
- Fixed Tuesday, July 21, 2026, as the Record Date for final dividend payment and the 28th AGM.
- Re-appointed Dr. Ramesh Kancharla as CMD and Dr. Dinesh Kumar Chirla as WTD for five years.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Final Dividend per Equity Share
₹3.5
🏢 How This Affects the Company
The recommendation of a final dividend impacts the company's cash flow, subject to shareholder approval at the upcoming AGM.
👥 What This Means For Shareholders
✅
Action Required
Shareholders must hold shares by July 21, 2026, to be eligible for the recommended final dividend, subject to approval at the AGM.
👤
Who Is Affected
Shareholders on record as of July 21, 2026, will be eligible for the final dividend of ₹3.5 per Equity Share, if approved at the 28th AGM.
🔍
Management Signal
Management intends to provide a return to shareholders through dividends and ensure continuity in leadership with the re-appointment of key directors.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Outcome of 28th Annual General Meeting on July 29, 2026.
Confirmation of final dividend payment post-AGM approval.
Announcement of results from the AGM regarding director re-appointments.
LOW RISK
The filing contains standard board meeting outcomes and no immediate risks.
💡 Investor Takeaway
Rainbow Children's Medicare Ltd's board approved FY26 audited financial results and recommended a final dividend of ₹3.5 per Equity Share. The Record Date for this dividend is July 21, 2026, with the 28th AGM scheduled for July 29, 2026.
⚖️ Strengths & Concerns
✅ Positives
- Recommendation of a final dividend of ₹3.5 per Equity Share for FY26 indicates a return to shareholders.
- Unmodified audit opinions for both standalone and consolidated financial results for FY26 confirm financial reporting integrity.
📅 Company Track Record
A previous filing on May 27, 2026, also indicated that the board had approved FY26 results and recommended a ₹3.5 final dividend per equity share, confirming consistency in these decisions.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What is the final dividend recommended by Rainbow Children's Medicare Ltd for FY26?
Rainbow Children's Medicare Ltd recommended a final dividend of ₹3.5 per Equity Share (@ 35%) on a face value of ₹10 per share for the Financial Year ended March 31, 2026.
When is the Record Date for the final dividend for Rainbow Children's Medicare Ltd?
The Record Date for the purpose of payment of Final Dividend for Financial Year 2025-26 (if approved) is fixed as Tuesday, July 21, 2026.
When is Rainbow Children's Medicare Ltd's 28th Annual General Meeting?
The 28th Annual General Meeting (AGM) of Rainbow Children's Medicare Ltd is scheduled for Wednesday, July 29, 2026.
Who was re-appointed as Chairman and Managing Director of Rainbow Children's Medicare Ltd?
Dr. Ramesh Kancharla (DIN: 00212270) was re-appointed as the Chairman and Managing Director of Rainbow Children's Medicare Ltd for a period of five consecutive years, from August 11, 2026, till August 10, 2031.
Questions based on this BSE filing only. For information purposes.